Clinical Trials
197 trialsShared Decision Making in Low Risk Prostate Cancer
Massachusetts General Hospital
PEM-PRO
IRCCS San Raffaele
TA-P-OLIM
University Hospital, Ghent
Robotic Telesurgery in Urology
Case Comprehensive Cancer Center
Superman
Canisius-Wilhelmina Hospital
Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Patient Recall of Cancer Screening and Diagnosis
Case Comprehensive Cancer Center
PROTOMEN
University Hospital, Rouen
Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells
Oncology Institute of Southern Switzerland
Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone
Northwestern University
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
Northwestern University
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence
University of Rochester
Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology
M.D. Anderson Cancer Center
REPRESENTATION
Latin American Cooperative Oncology Group
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
OHSU Knight Cancer Institute
CHEMOPROST
Institut Bergonié
TALON
Duke University
HRPCa-II
Assistance Publique - Hôpitaux de Paris
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Thomas Jefferson University
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer
M.D. Anderson Cancer Center
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer
IRCCS San Raffaele
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
Fred Hutchinson Cancer Center
Single-Port Versus Multi-Port Robotic Radical Prostatectomy
Case Comprehensive Cancer Center
Dynamic Whole Body PET/ MRI
British Columbia Cancer Agency
Prostate MRI and Pylarify PSMA PET/CT
Corewell Health East
Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis
Sir Mortimer B. Davis - Jewish General Hospital
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Sir Mortimer B. Davis - Jewish General Hospital
KOALA
Royal North Shore Hospital
A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer
Memorial Sloan Kettering Cancer Center
Using Meditation for Oncology Anxiety
Geisinger Clinic
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study
University of Alabama at Birmingham
Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors
Medical University of South Carolina
LUNAAR
Baptist Health South Florida
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Stanford University
TRACK
Western University, Canada
Neoadjuvant Listeria or Daratumumab in Prostate Cancer
M.D. Anderson Cancer Center
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
ARTGU
University Health Network, Toronto
A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
M.D. Anderson Cancer Center
HIIT PCa
The University of Texas Health Science Center at San Antonio
Focal Therapy for Localized Prostate Cancer
China Medical University Hospital
A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery
Chinese University of Hong Kong
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)
M.D. Anderson Cancer Center
Investigation of Protein Biomarkers of Prostate Cancer
University of New Mexico
Identification of Risk Allels for Prostate Cancer
University of New Mexico
Micro-RNA Expression Profiles in Localised Prostate Cancer
Wuerzburg University Hospital
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
University of Basel
A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer
Cedars-Sinai Medical Center